Get Adobe Flash player

T-BET, FOXP3 AND CD8 REGULATING IMMUNE RESPONSE IN COLORECTAL CANCER

Автор: Hassan Ali Al-Saadi

Сторінки: 438-441

Анотація

         

Colorectal cancer (CRC) is the third most common cancer diagnosed, and is associated with high rates of propagation and mortality for both men and women. Aimed to to analyze impact of presence of T-bet, Foxp3 and CD8 on colorectal cancer. During the period 1/October/2013 to 1/March/2014, fifty patients with colon cancer (14 female and 36 male) (7-75) years were taken from (Al-Hussain Hospital City/Kerbala, Digestive and Liver Disease /Education Hospital Medical City Baghdad and Teaching Oncology Hospital /Baghdad Medical City/ Baghdad /Iraq).Immunochemical studying of T-bet, Foxp3 and CD8 of colorectal biopsies by using DAKO Company/Denmark. There was a significant increase (p≤0.001) in the concentration of T-bet, Foxp3 and CD8 respectively in patients male compared with female, also there was a significant variance (p≤0.001) in the three age groups from (7-20), (21-40) and (41-75) in the levels of T-bet and CD8, whereas a significant difference (p≤0.05) in the concentration of Foxp3 in the three age groups. This study proved functional role of T-bet, Foxp3 and CD8 in cell-mediated immunity.
Key words: T-bet, Foxp3, CD8, Colorectal cancer.

Ця електронна адреса захищена від спам-ботів. вам потрібно увімкнути JavaScript, щоб побачити її.

Список літератури

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ. Cancer statistics, 2009. CA: a cancer journal for clinicians 2009; 59(4), 225-249.
    2. Zeestraten EC, Van Hoesel AQ, Speetjens FM, Menon AG, Putter H, van de Velde CJ, and Kuppen PJ. FoxP3-and CD8-positive infiltrating immune cells together determine clinical outcome in colorectal cancer. Cancer Microenvironment 2013; 6(1), 31-39.
    3. Goc J, Germain C, Vo-Bourgais TKD, Lupo A, Klein C, Knockaert S et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer research 2014; 74(3), 705-715.
    4. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, et al. Crucial role of FOXP3 in the development and function of human CD25+ CD4+ regulatory T cells. International immunology 2004; 16(11), 1643-1656.
    5. Hori S and Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes and Infection 2004; 6(8), 745-751.
    6. Gordon SM, Chaix J, Rupp LJ, Wu J, Madera S, Sun JC et al. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation.Immunity 2012; 36(1), 55-67.